Adverum Biotechnologies Inc. (ADVM) had a good day on the market for Monday April 15
shares jumped 11.57% to close at $5.69. About 1.24 million shares traded hands on 6,797 trades for the day, compared with an average daily volume of
n/a shares out of a total float of 63.2 million. After opening the trading day at $4.44, shares of Adverum Biotechnologies Inc. stayed within a range of $5.86 to
With today’s gains, Adverum Biotechnologies Inc. now has a market cap of
$359.61 million. Shares of Adverum Biotechnologies Inc. have been trading within a range of $7.73
and $2.62 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.
Adverum Biotechnologies Inc. is based out of Menlo Park, CA and has some 82 employees. Its CEO is Leone Patterson.
For a complete fundamental analysis of Adverum Biotechnologies Inc., check out Equities.com’s Stock Valuation Analysis report for
Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start
Adverum Biotechnologies Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell
Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.
To get more information on Adverum Biotechnologies Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
ADVM’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk. Also, don’t forget to sign-up for our daily
email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer